TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Bionordika AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,671
|
3,995
|
5,140 |
| Financial expenses |
37
|
69
|
66 |
| Earnings before taxes |
199
|
317
|
1,050 |
| Total assets |
1,716
|
1,623
|
2,533 |
| Current assets |
1,642
|
1,562
|
2,489 |
| Current liabilities |
1,005
|
957
|
1,792 |
| Equity capital |
607
|
655
|
722 |
| - share capital |
9
|
9
|
10 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.4%
|
40.4%
|
28.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
5.4%
|
7.9%
|
20.4% |
| Return on assets (ROA) |
13.8%
|
23.8%
|
44.1% |
| Current ratio |
163.4%
|
163.2%
|
138.9% |
| Return on equity (ROE) |
32.8%
|
48.4%
|
145.4% |
| Change turnover |
-120
|
-819
|
-1,318 |
| Change turnover % |
-3%
|
-17%
|
-20% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.